| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.24 | 4e-12 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.24 | 1e-11 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.23 | 1e-10 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.24 | 9e-10 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.27 | 3e-09 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.23 | 8e-09 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.31 | 2e-08 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.27 | 2e-08 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.2 | 8e-08 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-07 |